New Data Show Majority of Adults with Moderate to Severe Plaque Psoriasis Treated with First-in-Class TREMFYA ® (guselkumab) Experienced Durable Skin Clearance Through Five Years Regardless of Metabolic Syndrome Status, Baseline Disease Severity, or Treatment History
SPRING HOUSE, PENNSYLVANIA, March 25, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced its first-in-class interleukin (IL)-23 inhibitor TREMFYA® (guselkumab) provided a consistent, high degree of durable skin clearance through five years in a majority of adult patients across broad subpopulations with moderate to severe plaque psoriasis (PsO) in the Phase 3 VOYAGE 1 and VOYAGE 2 clinical trials.1 A separate post hoc analysis of the VOYAGE studies showed TREMFYA provided high rates of efficacy and durability through five years and similar safety outcomes among patients with and without...
Source: Johnson and Johnson - March 25, 2022 Category: Pharmaceuticals Source Type: news

Personal trainer father, 47, is given less than 18 months to live
Mark Potter, 47, from Essex, was given less than 18 months to live after he was diagnosed with stomach cancer that had spread to his spine. (Source: the Mail online | Health)
Source: the Mail online | Health - March 21, 2022 Category: Consumer Health News Source Type: news

South Africa: North West Health On World Salt Awareness Week
[Govt of SA] The North West Department of Health urge communities to take actions during the World Salt Awareness Week which is marked on 14 - 20 March. The awareness is to educate members of the public that salt can damage their health and it is linked to serious health conditions such as stroke and heart failure. There is also increasing evidence supporting links between our current high salt diets and the onset of stomach cancer, osteoporosis, obesity and kidney stones and kidney disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 15, 2022 Category: African Health Source Type: news

The Truth About Common Digestive Health Fears
Everyone experiences digestive problems now and then, and they’re nobody’s idea of a good time. In a survey of nearly 72,000 adults in the U.S., 61% reported having had at least one gastrointestinal (GI) symptom over the previous week, and within that group, 58% said they’d had two or more GI symptoms over the past week, according to a study in a 2018 issue of the American Journal of Gastroenterology. Because symptoms like constipation, heartburn, and abdominal pain are generally vague and often don’t have an obvious cause, those suffering tend to fear the worst. “People get very concerned abo...
Source: TIME: Health - March 14, 2022 Category: Consumer Health News Authors: Stacey Colino Tags: Uncategorized healthscienceclimate Source Type: news

'Strong evidence': The food that's a 'cause' of cancer - the average Briton eats too much
CANCER statistics remain dismal, despite the arrival of pioneering treatments and intensified efforts to raise awareness. You can modify your risk of the deadly disease, however. A report by the World Cancer Research Fund International uncovered "strong evidence" that a particular type of food consumed by millions of Britons is a "cause" of stomach cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - March 8, 2022 Category: Consumer Health News Source Type: news

Cancer warning: The vegetable associated with an 'elevated' risk of stomach cancer
CANCER is fiendishly difficult to treat once it has spread so early detection is key. Better still, you can modify your risk of developing the deadly disease in the first place. Research has drawn an association between a specific type of vegetable and an "elevated" risk of stomach cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - March 3, 2022 Category: Consumer Health News Source Type: news

Stomach Cancer: The bacterial infection that can increase your risk of the deadly disease
STOMACH cancer isn't the most common form of cancer in the UK, but symptoms of the condition can be hard to spot making it difficult to get an early diagnosis. One cause is an infection that can reduce the risk of cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2022 Category: Consumer Health News Source Type: news

Mansfield woman awaiting surgery to remove 8kg tumour
Stephanie Coles was diagnosed with a rare form of cancer after she found a lump on her stomach. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 15, 2022 Category: Consumer Health News Source Type: news

Mayo Clinic researchers develop model to predict treatment response in gastric cancer
JACKSONVILLE, FLA. ― A study by researchers at Mayo Clinic Cancer Center in Florida is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from chemotherapy or from immunotherapy. The study is published in Nature Communications. "Gastric cancer is among the leading causes of cancer-related death, worldwide," says Tae Hyun Hwang, Ph.D., the Florida Department of Health cancer chair at Mayo Clinic Cancer Center in Florida.… (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - February 14, 2022 Category: Hospital Management Source Type: news

Stomach cancer: Five of the 'first signs' that may arise - they are 'often vague'
THERE are many possible symptoms of stomach cancer, but they might be hard to spot, and are sometimes "vague" in nature. Stomach cancer is cancer that starts anywhere inside the stomach or the stomach wall. (Source: Daily Express - Health)
Source: Daily Express - Health - February 13, 2022 Category: Consumer Health News Source Type: news

Pancreatic cancer: Three sensations indicative of a 'tumour pressing on the stomach'
PANCREATIC cancer is typically diagnosed in the later stages, when symptoms of the disease become noticeable. As such, if you experience the following sensations, book an urgent appointment with your doctor. (Source: Daily Express - Health)
Source: Daily Express - Health - February 11, 2022 Category: Consumer Health News Source Type: news

Cancer: The food shown to have a 'direct association' to cancer - and it's not meat
THE RELATIONSHIP between cancer and diet is complex and inconclusive. Mounting evidence has found a strong association between certain food groups and an increased risk of cancer. A study published in the Nutrition and Cancer journal found a "direct association" between a popular food and stomach cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - February 11, 2022 Category: Consumer Health News Source Type: news

Gene expression profile could enable rapid identification of anti-tumor immune cells for personalized immunotherapy
Technique appears to have promise in stomach, esophageal, ovarian and breast cancers, among other types of tumors. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 3, 2022 Category: American Health Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021
Basel, 3 February 2022Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for newly launched medicines more than offsets impact of biosimilarsDiagnostics Divisionsales grow 29%; strong momentum in base business and continued high demand for COVID-19 testsMajor approvals for medicinessince the last quarter: United States: Susvimo and Vabysmo (age-related blindness)Europe: Gavreto (specific type of advanced lung cancer); Actemra/RoActemra (severe COVID-19); Ronapreve (non-hospitalised COVID-19 patients and prophylaxis)Major appro...
Source: Roche Investor Update - February 3, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021
Basel, 3 February 2022Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for newly launched medicines more than offsets impact of biosimilarsDiagnostics Divisionsales grow 29%; strong momentum in base business and continued high demand for COVID-19 testsMajor approvals for medicinessince the last quarter:United States: Susvimo and Vabysmo (age-related blindness)Europe: Gavreto (specific type of advanced lung cancer); Actemra/RoActemra (severe COVID-19); Ronapreve (non-hospitalised COVID-19 patients and prophylaxis)Major approvals f...
Source: Roche Media News - February 3, 2022 Category: Pharmaceuticals Source Type: news